Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.
Pavlinac PB, Rogawski McQuade ET, Platts-Mills JA, Kotloff KL, Deal C, Giersing BK, Isbrucker RA, Kang G, Ma LF, MacLennan CA, Patriarca P, Steele D, Vannice KS.
Pavlinac PB, et al.
Vaccines (Basel). 2022 Mar 22;10(4):489. doi: 10.3390/vaccines10040489.
Vaccines (Basel). 2022.
PMID: 35455238
Free PMC article.